Keli Walbert elected to Hemab board, joins Audit Committee
Hemab appointed Keli Walbert to its Board as a Class I director and named her to the Audit Committee, effective immediately.Original SEC Filing: Hemab Therapeutics Holdings, Inc. [ COAG ] - 8-K - Sep. 24, 2026This is an AI-powered summary. It may contain inaccuracies. Consider verifying important i…